Patents by Inventor Leonardo Alberto

Leonardo Alberto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9399109
    Abstract: A respiratory assistance device is disclosed. There is a variable speed blower with an output, and a patient ventilation interface configured for fitment on a patient respiratory passageway. A gas passage conduit couples the output of the blower to the patient ventilation interface. A pilot line from the gas passage conduit is coupled to a piloted exhalation valve of the patient ventilation interface. A pressure sensor measures a mask pressure in the patient ventilation interface, and a blower speed sensor measures a speed of the blower. A pressure controller in communication with the pressure sensor and the blower speed sensor detects a patient inspiratory phase and a patient expiratory phase from at least one of the measured speed of the blower and a set speed of the blower. The pressure controller adjusts an operating speed of the blower and actuates the piloted exhalation valve based upon the measured mask pressure.
    Type: Grant
    Filed: October 22, 2012
    Date of Patent: July 26, 2016
    Assignee: Breathe Technologies, Inc.
    Inventors: Leonardo Alberto Baloa Welzien, Enrico Brambilla, Samir S. Ahmad
  • Patent number: 9272106
    Abstract: Respiratory assistance is provided to a subject in the form of a pressurized flow of breathable gas. The pressure of the gas is eased during expiration and increased during inspiration. Changes in pressure are triggered and/or cycled based on the monitoring of tidal volume. Volume thresholds that cause triggering and/or cycling are adjusted based on an observed or measured breath rate.
    Type: Grant
    Filed: December 12, 2011
    Date of Patent: March 1, 2016
    Assignee: Koninklijke Philips N.V.
    Inventors: Sara Marie Sibenaller, Leonardo Alberto Baloa Welzien, Manuel Laura Lapoint
  • Patent number: 9207647
    Abstract: A personal alarm system that only wakes up the intended user includes an appliance worn near the eye. The personal alarm system emits radiation of a particular wavelength onto the eye or eyelid of the intended user and a predetermined moment to wake up the intended user.
    Type: Grant
    Filed: March 15, 2012
    Date of Patent: December 8, 2015
    Assignee: Koninklijke Philips N.V.
    Inventors: Leonardo Alberto Baloa Welzien, Michael Edward Colbaugh
  • Publication number: 20150231349
    Abstract: A method for detecting sleep for continuous positive airway pressure (CPAP) therapy is disclosed. Discrete values of a control signal generated by a pressure controller to regulate delivered pressure at the patient are measured over a predefined time window encompassing one or more respiratory cycles. A baseline control signal value is generated from a weighted average of the measured discrete values of the control signal. Estimates of a respiratory cycle period, an inspiration control time, and an expiration control time are then generated. Estimates of one or more secondary control signal properties for each of the respective inspiration control time and expiration control time are generated. Pressure to the patient is increased in response to an evaluation of the estimates of the one or more secondary control signal properties being indicative of the patient reaching a sleep state.
    Type: Application
    Filed: February 14, 2014
    Publication date: August 20, 2015
    Applicant: Breathe Technologies, Inc.
    Inventors: Samir S. Ahmad, Leonardo Alberto Baloa Welzien
  • Publication number: 20150231350
    Abstract: Methods for detecting a patient disconnecting from a continuous positive airway pressure (CPAP) therapy device are disclosed. A cyclical pressure difference signal is derived based upon measurements from a patient interface pressure sensor and from a source pressure sensor. The pressure difference signal is integrated to generate a resultant integral signal for each respiratory cycle, which is comprised of at least one inspiratory phase and at least one expiratory phase as represented by the corresponding portions of the pressure difference signal. A pressure source of the CPAP therapy device is deactivated in response to a disconnect condition being evaluated from the integral signal. In one embodiment, the disconnect condition is the integral signal exceeding a predefined disconnect threshold. In other, it is a slope value corresponding to a rate of increase of the integral signal exceeding a predefined threshold for a predefined duration.
    Type: Application
    Filed: February 14, 2014
    Publication date: August 20, 2015
    Applicant: Breathe Technologies, Inc.
    Inventors: Leonardo Alberto Baloa Welzien, Mark Pielemeier, Samir S. Ahmad
  • Publication number: 20150165143
    Abstract: Adapting a patient to an airway pressure support therapy is disclosed. An initial prescription pressure level is derived from a respiratory disturbance index diagnosis. A pressure ramping slope is generated from the initial prescription pressure level and a received initial pressure level. Increasing levels of pressure are delivered to the patient as defined by the pressure ramping slope. The pressure ramping slope is adjusted based upon derived usage duration trends, and the prescription pressure level is adjusted based upon measured apnea/hypopnea index variations resulting from the delivered increasing levels of pressure to the patient.
    Type: Application
    Filed: December 12, 2013
    Publication date: June 18, 2015
    Applicant: Breathe Technologies, Inc.
    Inventors: LEONARDO ALBERTO BALOA, MASOUD VAHIDI, SAMIR S. AHMAD
  • Patent number: 8985108
    Abstract: Indicating fit status of a mask in communication with a respiratory assistance device is disclosed. Upon initiating a therapeutic gas delivery from the respiratory assistance device to the mask, one or more measurements from respective one or more sensors of the respiratory assistance device is received. A leakage value from these measurements is derived, and a mask fit index is assigned. This is based at least upon a correlation of the leakage value to a particular sub-range of predetermined leakage values that corresponds to the mask fit index. The particular sub-range of predetermined leakage values is one among a plurality of sub-ranges, which together comprises an overall mask fit range defined at least by an ideal mask fit region, a loose mask fit region, and a tight mask fit region. A mask fit status based upon the assigned mask fit index is output to an indicator interface.
    Type: Grant
    Filed: April 6, 2012
    Date of Patent: March 24, 2015
    Assignee: Breathe Technologies, Inc.
    Inventors: Samir S. Ahmad, Leonardo Alberto Baloa Welzien, Enrico Brambilla, Lauren Cheney, Iva Segalman, Simon Johnson
  • Publication number: 20150068528
    Abstract: A comfort signature that naturally adapts delivered pressure to patient breathing by measuring comfort directly from the source is disclosed. Pressure is measured at the patient interface and is used to provide a comfortable and suitable target pressure adjustment that is synchronized with patient respiration.
    Type: Application
    Filed: September 10, 2014
    Publication date: March 12, 2015
    Inventors: SAMIR S. AHMAD, DONGBING WEI, MARK PEILEMEIER, LEONARDO ALBERTO BALOA-WELZIEN
  • Publication number: 20150068529
    Abstract: A respiratory assistance device is disclosed. There is a patient interface for coupling to a patient respiratory passageway, and a selectively regulated therapeutic gas flow source in pneumatic communication with the patient over the patient interface. A controller is connected to the therapeutic gas flow source and is receptive to inputs of a prescription pressure level and an initial delay duration. After the patient dons the patient interface, therapeutic gas flow is restricted for the initial delay duration following receipt of a treatment initiation command. Upon the expiry of the initial delay duration, the controller increases therapeutic gas flow to the prescription pressure level.
    Type: Application
    Filed: September 10, 2014
    Publication date: March 12, 2015
    Inventors: SAMIR S. AHMAD, LEONARDO ALBERTO BALOA-WELZIEN
  • Publication number: 20150073291
    Abstract: The identification of obstructed breathing, including an apnea condition and a hypopnea condition, is disclosed. A signal representative of a flow rate of therapeutic gas being delivered to the patient is received. A peak flow value and a minimum flow value over a predetermined time window encompassing a plurality of respiration cycles is derived. A polynomial difference equation from the peak flow values and the minimum flow values is generated, and a respiration index from a minimum of the polynomial difference equation is derived. The apnea and/or hypopnea condition is indicated based upon a comparison of the respiration index to a predefined obstruction threshold over a predefined obstruction time period.
    Type: Application
    Filed: September 6, 2013
    Publication date: March 12, 2015
    Applicant: Breathe Technologies, Inc.
    Inventors: Leonardo Alberto Baloa Welzien, Enrico Bambrilla, Samir S. Ahmad
  • Patent number: 8960192
    Abstract: The lung compliance of a subject that is at least partially self-ventilating is determined. The quantification of lung compliance may be an estimation, a measurement, and/or an approximate measurement. The quantification of lung compliance may be enhanced over conventional techniques and/or systems for quantifying lung compliance of self-ventilating subjects in the lung compliance may be quantified relatively accurately without an effort belt or other external sensing device that directly measures diaphragmatic muscle pressure, and without requiring the subject to manually control diaphragmatic muscle pressure. Quantification of lung compliance may be a useful tool in evaluating the health of the subject, including detection of fluid retention associated with developing acute congestive heart failure.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: February 24, 2015
    Assignee: Koninklijke Philips N.V.
    Inventors: Leonardo Alberto Baloa Welzien, Nathan Francis O'Connor
  • Publication number: 20150011905
    Abstract: A single respiratory cycle flow limitation detection method is disclosed. A patient gas delivery signal is received from one or more sensors in pneumatic communication with a ventilation source and a patient ventilation interface to a patient airway. The patient gas delivery signal is representative of a measure of therapeutic gas being delivered to the patient airway at a given time instant, and spans the single patient respiratory cycle. A second derivative of the patient gas delivery signal is generated and a total number of zero crossings therein are counted. These zero crossings are representative of an inflection change in the patient gas delivery signal. A flow limitation indication corresponding to the identified flow limitation is generated when there are at least two zero crossings in the second derivative of the patient gas delivery signal. An angle of deformation representing early, late, or mid-cycle obstruction onsets is generated.
    Type: Application
    Filed: July 3, 2013
    Publication date: January 8, 2015
    Inventors: Leonardo Alberto Baloa Welzien, Samir S. Ahmad
  • Publication number: 20140373835
    Abstract: In accordance with the present invention, there is provided is provided a tubing arrangement and associated connectors, including a delivery adaptor and a Y-connector, which may be used to facilitate the operative interface of a patient interface to a ventilator within a ventilation system. The delivery adaptor is connected between the outlet connector of the flow generator and the main delivery tube (i.e., the quad-lumen tube) in the ventilation system. The delivery adaptor functions to retain the pneumatic isolation of a sense line of the ventilation system from certain other lumens of the quad-lumen tube, and further connects one of the small lumens of the quad-lumen tube to an external oxygen source or an external humidification source. The oxygen or humidification is delivered to such lumen through the adaptor. The oxygen or humidification is then bled into the air stream at the outlet of such lumen which is at the Y-connector.
    Type: Application
    Filed: June 25, 2013
    Publication date: December 25, 2014
    Inventors: Samir S. Ahmad, Mark J. Zechmeister, Enrico Brambilla, Leonardo Alberto Baloa Welzien
  • Patent number: 8876728
    Abstract: The lung compliance of a subject that is at least partially self-ventilating is determined. The quantification of lung compliance may be an estimation, a measurement, and/or an approximate measurement. The quantification of lung compliance may be enhanced over conventional techniques and/or systems for quantifying lung compliance of self-ventilating subjects in the lung compliance may be quantified relatively accurately without an effort belt or other external sensing device that directly measures diaphragmatic muscle pressure, and without requiring the subject to manually control diaphragmatic muscle pressure. Quantification of lung compliance may be a useful tool in evaluating the health of the subject, including detection of fluid retention associated with developing acute congestive heart failure.
    Type: Grant
    Filed: July 30, 2010
    Date of Patent: November 4, 2014
    Assignee: Koninklijke Philips N.V.
    Inventors: Leonardo Alberto Baloa Welzien, Nathan Francis O'Connor
  • Publication number: 20140261426
    Abstract: A patient ventilation apparatus is disclosed. The apparatus includes an inlet port connectible to an oxygen source with pressurized oxygen enriched gas. An outlet port is connectible over a gas delivery conduit to a patient interface configured for fitment on a patient respiratory passageway. A valve is in pneumatic communication with the inlet port and with the outlet port. A first pressure sensor measures a patient interface pressure, which is connectible to the first pressure sensor over a pressure sensor line. A second pressure sensor measures a valve output pressure. A controller is in communication with the first pressure sensor, the second pressure sensor, and the flow sensor, to detect a patient inspiratory phase and a patient expiratory phase based upon a combination of measurements of the first pressure sensor and the second pressure sensor and to regulate the valve to selectively deliver pressurized oxygen enriched gas to the patient interface.
    Type: Application
    Filed: March 15, 2013
    Publication date: September 18, 2014
    Applicant: BREATHE TECHNOLOGIES, INC.
    Inventors: Samir S. Ahmad, Leonardo Alberto Baloa Welzien, Enrico Brambilla
  • Publication number: 20140276168
    Abstract: Mouth-breathing can be detected in early phase expiration during respiratory treatments involving a pressure support device. In accordance with some embodiments, an output signal is received from a sensor that conveys information relating to one or more parameters of the pressurized flow of breathable gas as it is delivered to an air-way of a subject. Transitions are estimated between inspiratory phases and expiratory phases of respiration by the subject based on the one or more determined parameters. A local extreme is identified in a level of a first parameter during a given expiratory phase of respiration by the subject. The level of the first parameter is analyzed as a function of time within a sampling window to determine whether the subject is breathing by mouth during the given expiratory phase. The sampling window begins at or proximate to the identified local extreme in the level of the first parameter.
    Type: Application
    Filed: October 11, 2012
    Publication date: September 18, 2014
    Inventors: Surya Subrahmanya Sreeram Vissapragada Venkata Satya, Leonardo Alberto Baloa Welzien, Manuel Laura Lapoint
  • Publication number: 20140034055
    Abstract: A respiratory assistance device is disclosed. There is a patient interface for coupling to a patient respiratory passageway, and a selectively regulated therapeutic gas flow source in pneumatic communication with the patient over the patient interface. A ramping controller is connected to the therapeutic gas flow source and is receptive to inputs of a prescription pressure level, an initial pressure level, a total ramp duration, and a numeric value corresponding to a ramping duration. Therapeutic gas flow at an initial pressure level is regulated for a ramp delay duration reciprocal to the ramping duration relative to the total ramp duration. The ramping controller incrementally increases therapeutic gas flow to the prescription pressure level from a ramp start time to a ramp end time at a delivery pressure increase rate derived from the numeric value of the ramping duration and the total ramp duration.
    Type: Application
    Filed: August 3, 2012
    Publication date: February 6, 2014
    Inventors: Leonardo Alberto Baloa Welzien, Samir S. Ahmad
  • Publication number: 20140020688
    Abstract: A pressure support system (10) including a pressure generator that generates a pressurized flow of breathable gas to a subject and a processor (22) configured to execute computer program modules. The modules include a first mode module (32) controls the pressure generator according to a first mode of therapy wherein breathing cues are provided to the subject (12) according to a breathing regime. The breathing cues prompt the subject to consciously alter breathing parameters. The modules also include a second mode module (34) controls the pressure generator according to a second mode of therapy wherein the flow of breathable gas is provided to the subject (12) at a selected pressure or selectively variable pressures. The modules further include a transition module (36) that transitions between the first mode of therapy and a second mode of therapy wherein parameters of the pressurized flow of breathable gas is adjusted in response to a trigger event.
    Type: Application
    Filed: March 28, 2012
    Publication date: January 23, 2014
    Applicant: KONINKLIJKE PHILIPS N.V.
    Inventors: Sara Marie Sibenaller, Manuel Laura Lapoint, Leonardo Alberto Baloa Welzien
  • Publication number: 20140014111
    Abstract: Methods and systems to treat Cheyne-Stokes respiration (CSR) and/or central sleep apnea (CSA) include monitoring retrograde breathing and detecting respiratory events. Based on the occurrences of certain respiratory events, a target volume of rebreathing is adjusted to reduce arousals as well as CSR/CSA.
    Type: Application
    Filed: March 20, 2012
    Publication date: January 16, 2014
    Applicant: KONINKLIJKE PHILIPS N.V.
    Inventors: Manuel Laura Lapoint, Leonardo Alberto Baloa Welzien
  • Publication number: 20140009282
    Abstract: A personal alarm system that only wakes up the intended user includes an appliance worn near the eye. The personal alarm system emits radiation of a particular wavelength onto the eye or eyelid of the intended user and a predetermined moment to wake up the intended user.
    Type: Application
    Filed: March 15, 2012
    Publication date: January 9, 2014
    Applicant: KONINKLIJKE PHILIPS N.V.
    Inventors: Leonardo Alberto Baloa Welzien, Michael Edward Colbaugh